NCT03117361 2020-12-02Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and LenalidomidePharmaMarPhase 2 Terminated10 enrolled 37 charts